Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy

Journal of Gastroenterology, 06/08/2012

The immunological responses of the HBV–high/HCV–high patient were low in comparison to the responses in HBV and HCV monoinfected patients. Moreover, the response of immune cells in the HBV–high/HCV–high patient during pegylated interferon/ribavirin (Peg–IFN/RBV) therapy was insufficient to suppress hepatitis B virus and hepatitis C virus (HBV/HCV).

Print Article Summary Cat 2 CME Report